Dracaena cinnabari (Asparagaceae) Dragon's Blood Tree, Dam Alakhwin
Dracaena cinnabari, the Dragon's Blood Tree of Socotra, is a botanical relic that has outlived the world that shaped it. The tree's famous crimson resin, harvested by cutting the bark, has been traded since antiquity as a dye, a medicine, and a ritual substance. Local communities on Socotra use it for dermal, dental, eye, and gastrointestinal complaints, a practice that modern research has begun to validate through documented antimicrobial, antifungal, and anticancer activities . The tree itself is unmistakable: a dense, umbrella-shaped canopy of stiff leaves crowning a thick trunk, a form so distinctive that it has become the emblem of the Socotra archipelago. Yet the species is in trouble. Its populations are aging, regeneration has nearly ceased, and climate models project a 45 percent reduction in its habitat by 2080 .
---
1. Taxonomic Insights
Species: Dracaena cinnabari Balf.f.
Family: Asparagaceae (formerly Dracaenaceae or Ruscaceae)
Genus: Dracaena
Basionym: Dracaena cinnabari Balf.f., Trans. & Proc. Bot. Soc. Edinburgh 30: 623 (1882)
Homotypic synonym: Draco cinnabari (Balf.f.) Kuntze
---
Botanical Description
Dracaena cinnabari is a monocotyledonous tree, typically 9 to 18 metres tall, with a straight or branched, strong trunk approximately 30 centimetres in diameter . The tree's growth habit is termed "dracoid habitus," a form shared with other Dracaena species in which the trunk branches dichotomously at maturity, producing the characteristic umbrella-shaped crown . The species is exceptionally long-lived, with individual trees estimated at several hundred years old, and it requires roughly a century to reach maturity .
Key Identification Features:
The leaves are leathery, sword-shaped, and clustered only at the tips of the youngest branches. They are shed every three to four years, with new leaves maturing simultaneously across the crown . This periodic leaf renewal gives the canopy its dense, uniform appearance.
The flowers are borne in clusters of two to five on racemes or panicles. The fruit is a small, fleshy berry containing one to four seeds, which turn from green to orange as they ripen. Each seed weighs approximately 68 milligrams and measures 4 to 5 millimetres in diameter .
The most celebrated feature is the resin. When the bark is cut or the tree injured, a blood-red sap exudes and hardens into "dragon's blood," a substance that has been harvested for millennia .
Distribution: Dracaena cinnabari is endemic to Socotra Island, Yemen, where it grows in the highlands and mountains of the central and eastern parts of the island at altitudes from 323 to 1,483 metres. It is absent from the coastal plains and lowlands below 180 metres . The species occupies only 5 percent of its current potential habitat in Yemen .
Conservation Status: The IUCN Red List categorises Dracaena cinnabari as Vulnerable . The population is aging, with limited natural regeneration, and the species faces threats from habitat degradation, overharvesting of resin, overgrazing by livestock, climate change, and increasingly frequent tropical storms . A progressive drought scenario projects a 45 percent reduction in current habitat by 2080 .
---
Etymology
The generic name Dracaena is derived from the Greek "drakaina," meaning female dragon, a reference to the blood-red resin. The specific epithet cinnabari refers to cinnabar, the bright red mercury sulfide mineral, alluding to the resin's vivid colour. The Arabic name "Dam Alakhwin" translates to "blood of the two brothers," reflecting local legend.
---
2. Common Names
Scientific Name: Dracaena cinnabari | English: Dragon's Blood Tree, Socotra Dragon Tree | Arabic: Dam Alakhwin (دم الأخوين) | Socotri: Arheb | French: Dragonnier de Socotra | German: Drachenblutbaum | Spanish: Árbol de la Sangre de Dragón
---
3. Related Herbs from the Asparagaceae Family
Dracaena cinnabari belongs to the Asparagaceae, a family that includes agaves, yuccas, hyacinths, and the genus Dracaena, whose members are united by their production of steroid saponins, flavonoids, and stilbenoids.
Dracaena draco (Canary Islands Dragon Tree): The closest well-known relative, native to the Canary Islands and Madeira. It produces a similar red resin and shares the iconic umbrella canopy. Genetic evidence indicates D. cinnabari has been evolutionarily isolated from D. draco for millions of years .
Dracaena cochinchinensis (Chinese Dragon's Blood): A source of dragon's blood used in traditional Chinese medicine, containing homoisoflavonoids with PTP1B inhibitory and neuroprotective activities .
Dracaena arborea: A West African species whose aqueous extract has demonstrated androgenic properties in diabetic rats, suggesting reproductive benefits .
The Asparagaceae, particularly the genus Dracaena, is characterised by the production of flavonoids (especially homoisoflavonoids and chalcones), steroids, and stilbenoids. These compounds contribute to the genus's documented analgesic, anti-inflammatory, antimicrobial, antioxidant, and cytotoxic activities .
---
4. Medicinal Uses: Summary of Primary and Secondary Actions
Primary Actions:
Antimicrobial: Resin extracts demonstrate effective antibacterial properties against several bacterial species, including Bacillus subtilis, Staphylococcus aureus, Micrococcus luteus, Shigella flexneri, Proteus mirabilis, Enterobacter aerogenes, and Escherichia coli. The dichloromethane extract showed the strongest inhibitory effect against foodborne pathogens .
Antifungal: The methanolic solution of the whole resin showed strong antifungal activity, particularly against Microsporum gypseum and Trichophyton mentagrophytes, dermatophytes responsible for skin and nail infections. This activity supports the traditional use of the resin for skin diseases and mouth fungal infections .
Anticancer: The resin has demonstrated significant cytotoxic and apoptosis-inducing effects on human oral squamous cell carcinoma. In vitro, ether and ethyl acetate extracts inhibited MCF-7 breast cancer cells by 50 percent at 100 micrograms per millilitre. In vivo, a methanol extract reduced the incidence of oral squamous cell carcinoma in mice in a dose-dependent manner, with the 1000 mg/kg dose inhibiting expression of cyclin D1, Ki-67, Bcl-2, and p53 while inducing apoptosis through Bax upregulation .
Antioxidant: The homoisoflavonoid 7,8-methylenedioxy-3(4-hydroxybenzyl)chromane exhibited strong antioxidant activity comparable to quercetin, one of the most potent known flavonol antioxidants .
Secondary Actions:
Wound Healing: Preclinical studies have shown promising results for the resin's wound-healing properties, consistent with its traditional use for dermal conditions .
Anti-inflammatory: The resin contains bioactive compounds including alkaloids, flavonoids, and phenolic acids with demonstrated anti-inflammatory properties in preclinical studies .
Antispasmodic and Relaxant: The resin has documented muscle relaxant effects, contributing to its traditional use for gastrointestinal complaints .
---
Medicinal Parts
Resin (Dragon's Blood): The primary medicinal substance. Harvested by cutting the bark, the resin is used for dermal, dental, eye, and gastrointestinal diseases in Socotri folk medicine . It is also used as a dye and in ritual contexts .
Leaves and Roots: Sterols and triterpenoids have been isolated from the roots and resin, including lupeol and betulin, compounds with documented anti-inflammatory and anticancer activities .
---
5. Phytochemistry
5.1 Flavonoids and Homoisoflavonoids
The resin of Dracaena cinnabari is dominated by flavonoids, particularly homoisoflavonoids and chalcones, which are the primary bioactive constituents.
7,8-Methylenedioxy-3(4-hydroxybenzyl)chromane: A homoisoflavonoid with antioxidant activity comparable to quercetin .
7-Hydroxy-3-(3-hydroxy-4-methoxybenzyl)chroman: A novel flavonoid isolated from the resin, along with (2S)-7,3'-dihydroxy-4'-methoxyflavan and 4-hydroxy-2-methoxydihydrochalcone .
2,4'-Dihydroxy-4-methoxydihydrochalcone and 2,4'-Dihydroxy-4-methoxyhydrochalcone: Two chalcone derivatives isolated from the red resin .
Dracidione: A C-linked chalcone-dihydrochalcone dimer isolated from the resin .
Cinnabarone and Damalachawin: Flavonoid compounds identified in the species .
5.2 Sterols and Triterpenoids
A comprehensive sterol and triterpenoid profile has been established for the resin and roots, including cholesterol, campesterol, stigmasterol, sitosterol, lupeol, and betulin. Additional compounds include cholest-4-en-3-one, 4α-methylcholest-7-en-3β-ol, 31-norcycloartanol, and cycloartanol .
5.3 Volatile Compounds
β-Caryophyllene: A sesquiterpene identified as the single volatile liquid constituent extracted from the resin. Its presence serves as a purity marker for authentic Soqotri resin .
Other constituents: The resin contains low volatile content, and the isolation of β-caryophyllene provides a means to distinguish genuine resin from adulterated market samples .
5.4 Other Compounds
A total of 25 different compounds have been isolated from Dracaena cinnabari, including cis-13-octadecenoic acid, N-hexadecenoic acid, beta-sitosterol, and N-heptadecanol-1 .
---
6. Mechanisms of Action
6.1 Anticancer Activity: Apoptosis Induction and Cell Cycle Arrest
The anticancer mechanism of Dracaena cinnabari resin has been characterised in oral squamous cell carcinoma models. Methanolic extract induces apoptosis and cytotoxic effects in H103 tongue squamous cell carcinoma cells in a dose- and time-dependent manner, causing morphological changes and cell cycle arrest at S and G2/M phases . In vivo, the extract inhibited expression of cyclin D1, Ki-67, Bcl-2, and p53 proteins and induced apoptosis through upregulation of Bax and Casp3, alongside downregulation of Tp53, Bcl-2, Cox-2, cyclin D1, and EGFR . The incidence of squamous cell carcinoma in induced oral cancer was 85.7 percent in untreated mice, but dropped to 57.1, 28.6, and 14.3 percent in groups receiving 100, 500, and 1000 mg/kg of extract, respectively .
6.2 Antimicrobial Activity: Membrane and Enzyme Disruption
The antimicrobial activity of the resin is attributed to its flavonoid content, particularly the chalcones and homoisoflavonoids. The dichloromethane extract showed maximum antibacterial potential against a range of foodborne pathogens . The mechanism likely involves disruption of microbial cell membranes and inhibition of essential enzymes, though specific targets have not been identified. The strong antifungal activity against dermatophytes suggests interference with fungal cell wall synthesis or membrane integrity .
6.3 Antioxidant Activity: Flavonoid Radical Scavenging
The homoisoflavonoid 7,8-methylenedioxy-3(4-hydroxybenzyl)chromane demonstrates antioxidant activity comparable to quercetin, indicating potent radical scavenging capacity . This activity is attributed to the phenolic hydroxyl groups on the flavonoid skeleton, which donate hydrogen atoms to neutralise free radicals.
---
7. Traditional and Ethnobotanical Uses
7.1 Dermal Diseases and Wounds
Formulation: Resin applied topically.
Preparation and Use: The resin is applied directly to the skin for the treatment of dermal diseases, wounds, and infections. In Socotri folk medicine, it is widely used for skin conditions .
Scientific Validation: The strong antifungal activity against Microsporum gypseum and Trichophyton mentagrophytes, along with documented antimicrobial and wound-healing properties, provides a rational basis for this use .
7.2 Dental and Oral Infections
Formulation: Resin applied to the mouth or chewed.
Preparation and Use: The resin is used for dental and mouth fungal infections in traditional Socotri medicine .
Scientific Validation: The antifungal activity against dermatophytes and the resin's documented antimicrobial properties support this use. The anticancer activity against oral squamous cell carcinoma further suggests potential for oral health applications .
7.3 Eye Diseases
Formulation: Resin preparation applied to the eyes.
Preparation and Use: The resin is used for eye diseases in Socotri folk medicine .
Scientific Validation: No specific pharmacological studies have evaluated the resin's ophthalmic activity. The traditional use warrants investigation given the resin's anti-inflammatory and antimicrobial properties.
7.4 Gastrointestinal Diseases
Formulation: Resin consumed orally.
Preparation and Use: The resin is used for gastrointestinal diseases, consistent with its documented antispasmodic and relaxant effects .
Scientific Validation: The muscle relaxant properties of the resin provide mechanistic support for its use in gastrointestinal complaints .
7.5 Dye and Ritual Uses
Formulation: Resin used as pigment.
Preparation and Use: Dragon's blood was used as a natural dye for textiles, pottery, and religious rituals. It was also used to extract a vivid red pigment .
---
8. Healing Recipes, Teas, Decoctions, and Practical Applications
8.1 Resin Paste for Skin Infections
Purpose: To treat fungal and bacterial skin infections.
Preparation and Use: Take a small piece of authentic Dracaena cinnabari resin. Dissolve in a minimal amount of methanol or warm water to form a paste. Apply directly to affected areas of skin. The methanolic solution of the whole resin showed the strongest antifungal activity in laboratory testing .
Scientific Validation: The methanolic resin solution demonstrated strong activity against Microsporum gypseum and Trichophyton mentagrophytes, dermatophytes responsible for skin infections .
8.2 Resin Solution for Oral Hygiene
Purpose: To address mouth fungal infections and support oral health.
Preparation and Use: Dissolve a small amount of resin in water or methanol and use as a mouth rinse. The traditional use for mouth fungal infections is documented in Socotri ethnobotanical surveys .
Scientific Validation: Antifungal activity against oral pathogens and anticancer activity against oral squamous cell carcinoma cells provide support for this application .
---
9. Clinical Significance and Evidence Summary
9.1 Evidence Hierarchy by Activity
Anticancer: Moderate evidence from in vitro and in vivo animal studies. The resin demonstrates significant cytotoxicity against oral squamous cell carcinoma and breast cancer cell lines, and reduces tumour incidence in mice. Human clinical trials are lacking .
Antifungal: Moderate evidence from in vitro studies. The methanolic resin solution shows strong activity against dermatophytes. The activity supports traditional use for skin and mouth infections .
Antimicrobial: Moderate evidence from in vitro studies. The dichloromethane extract demonstrates broad-spectrum antibacterial activity against foodborne pathogens .
Antioxidant: Preliminary evidence from in vitro studies. The homoisoflavonoid 7,8-methylenedioxy-3(4-hydroxybenzyl)chromane shows activity comparable to quercetin .
9.2 Clinical Trial Data
No clinical trials have been conducted on Dracaena cinnabari resin or extracts. All evidence comes from in vitro experiments and animal studies.
9.3 Safety and Toxicology Data
No formal toxicological studies have been published. The resin has been used in traditional medicine for centuries, but no LD50 values or organ toxicity profiles are available. The species' Vulnerable conservation status and slow growth mean that any therapeutic use must be balanced against sustainability concerns.
---
10. Safety and Toxicology
10.1 Toxicity Profile
Acute Toxicity: No data available.
Clinical Safety: Not established. The resin is used traditionally, but no controlled safety studies exist.
Reproductive and Developmental Toxicity: No data available.
10.2 Contraindications and Precautions
Pregnancy and Lactation: Avoid medicinal use without professional supervision, as safety data is lacking.
Known Hypersensitivity: Individuals with known hypersensitivity to Asparagaceae plants should use with caution.
Conservation Concern: The species is Vulnerable and has slow regeneration. Harvesting resin from wild trees contributes to population decline. Source only from sustainably managed or cultivated sources.
10.3 Potential Drug Interactions
No drug interaction studies have been conducted. Theoretically, the resin's anticoagulant or antiplatelet effects (if any) could interact with blood-thinning medications, but no specific interactions are documented.
---
11. Quality Control Parameters
11.1 Marker Compounds for Standardisation
β-Caryophyllene serves as a purity marker for authentic Soqotri resin, as it was identified as the single volatile constituent . 7,8-Methylenedioxy-3(4-hydroxybenzyl)chromane serves as a marker for antioxidant activity . The homoisoflavonoids and chalcones can serve as markers for the resin's overall flavonoid content.
11.2 Recommended Analytical Methods
Gas chromatography-mass spectrometry (GC-MS) is recommended for β-caryophyllene quantification and purity assessment . High-performance liquid chromatography (HPLC) with diode array detection is recommended for flavonoid profiling. The agar diffusion method is used for antifungal activity assessment . DPPH assay is used for antioxidant activity .
11.3 Suggested Specifications
Authentic resin should dissolve completely in methanol, a property used to distinguish pure resin from adulterated market samples . Organoleptic properties, solubility, and extractive value serve as preliminary identification methods .
---
12. Cultivation and Sustainability
12.1 Growth Requirements
Climate: Arid tropical. The species grows in the dry shrubland biome of Socotra, where it captures moisture from monsoon mist through its canopy .
Habitat: Highland mountains and plateaus, typically in regions frequently enveloped by fog .
Altitude: 323 to 1,483 metres above sea level .
Soil: Rocky limestone terrain of Socotra's highlands.
Propagation: From seed. Regeneration is severely limited by overgrazing and climate change. Seedlings are rarely found in the wild, and the population is aging .
12.2 Sustainable Harvesting
Plant parts harvested: Resin is harvested by cutting the bark. The resin is collected only once per year, contributing to its high market value .
Harvesting method: Traditional tapping involves making incisions in the bark and collecting the exuded resin. Unsustainable harvesting is one of the threats to the species .
Caution: Given the Vulnerable conservation status, resin should be sourced only from sustainably managed populations. Wild harvesting contributes to population decline.
12.3 Conservation Status
Dracaena cinnabari is classified as Vulnerable by the IUCN . The species occupies only 5 percent of its potential habitat, and climate models project a 45 percent reduction by 2080 . Threats include habitat fragmentation, an aging population, unsustainable resin harvesting, overgrazing by goats and sheep, climate change, and tropical storms . Conservation efforts focus on community-based management, protection of regeneration sites, and raising awareness of the species' ecological and cultural significance .
---
13. Cultivar and Varietal Comparison
No cultivars or varieties of Dracaena cinnabari have been formally described. The species exhibits genetic distinctiveness from its closest relatives, with genetic studies indicating millions of years of evolutionary isolation from Dracaena draco of the Canary Islands, approximately 5,000 kilometres away .
---
14. Research Gaps and Future Directions
14.1 Critical Research Gaps
Human Clinical Trials: No clinical trials have been conducted for any indication. The anticancer and antifungal activities warrant clinical investigation.
Mechanistic Studies: The molecular targets of the resin's anticancer and antimicrobial compounds require further characterisation.
Safety and Toxicology: Comprehensive toxicological studies are lacking.
Volatile Metabolites: Further investigations regarding volatile metabolites of the resin are needed due to the limited number of current reports .
Conservation Genetics: Research on genetic diversity and population structure is needed to inform conservation strategies.
14.2 Future Research Priorities
Anticancer Drug Development: The resin's demonstrated activity against oral squamous cell carcinoma and breast cancer cells, with selectivity for cancer cells over normal cells, warrants further investigation as a lead for anticancer drug development.
Antifungal Applications: The strong activity against dermatophytes suggests potential for development of topical antifungal products, subject to sustainable sourcing.
Conservation and Cultivation: Research on propagation, cultivation, and sustainable resin harvesting is urgently needed to protect the species while allowing continued use of its medicinal resin.
---
15. Commercial Applications
15.1 Pharmaceutical Research
The resin's anticancer and antifungal activities warrant development as a source of lead compounds for drug discovery, provided sustainable sourcing can be ensured.
15.2 Cosmetics and Dyes
Dragon's blood resin has been used as a natural dye and pigment since antiquity. It continues to be valued in cosmetics and artisanal products .
15.3 Conservation and Ecotourism
The Dragon's Blood Tree is the flagship species of Socotra, a UNESCO World Heritage site. Ecotourism centred on the species provides economic incentive for conservation, though it must be managed to avoid damaging fragile populations .
---
16. Related Plants for Further Study
Dracaena draco (Canary Islands Dragon Tree): The closest well-known relative, sharing the red resin and umbrella canopy. Comparative studies could reveal chemical differences shaped by millions of years of isolation.
Dracaena cochinchinensis (Chinese Dragon's Blood): A source of dragon's blood in traditional Chinese medicine, containing homoisoflavonoids with neuroprotective and PTP1B inhibitory activities .
Dracaena arborea: A West African species with documented androgenic effects in diabetic rats, suggesting reproductive benefits that warrant comparative investigation .
---
17. Reference Literature
Primary Research
2024 book chapter in ScienceDirect reviews the traditional use of Dracaena cinnabari, the importance of its resin, and bioactivity studies of isolated chemical structures, documenting antimicrobial activity and 25 isolated compounds .
2021 review in BioMed Research International (NIH) comprehensively covers the phytochemistry and pharmacological activities of Dracaena cinnabari resin, including detailed anticancer data from in vitro and in vivo studies .
2018 study in Plants (Basel) documents the ethnobotanical survey of Dracaena cinnabari and investigates the antifungal and antioxidant activity of its resin, confirming traditional uses for skin and mouth fungal infections .
2000 study in Phytochemistry reports the isolation of sterols and triterpenoids from the resin and roots of Dracaena cinnabari .
2000 study in Phytochemistry reports the isolation of flavonoids from dragon's blood, including three new compounds .
Taxonomic and Conservation Sources
Kew Plants of the World Online provides authoritative taxonomic and distribution data .
The 2021 review in BioMed Research International provides detailed botanical description and distribution data .
Mongabay (2025) provides conservation context, including the species' ecological role and threats .
---
18. Disclaimer
Dracaena cinnabari resin has been used in traditional medicine, but formal safety data are lacking. Medicinal preparations should not be used without professional supervision.
This information is for educational and academic purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
The species is classified as Vulnerable by the IUCN. Wild harvesting of resin contributes to population decline. Source any products only from sustainably managed or cultivated sources.
Pregnant or nursing women should avoid medicinal use due to lack of safety data.
Always consult a qualified healthcare practitioner before using any plant for medicinal purposes.
Comments